These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 3383182)
1. Charge heterogeneity of human mammary tumor estrogen receptors. Relationship with a hormonal sensitivity tumor marker. Bailleul S; Gauduchon P; Malas JP; Lechevrel C; Roussel G; Goussard J Cancer Lett; 1988 Jun; 40(3):299-307. PubMed ID: 3383182 [TBL] [Abstract][Full Text] [Related]
2. Steroid receptors analysis in human mammary tumors by isoelectric focusing in agarose. Bailleul S; Gauduchon P; Malas JP; Lechevrel C; Roussel G; Goussard J Anal Biochem; 1988 Aug; 172(2):311-9. PubMed ID: 3189782 [TBL] [Abstract][Full Text] [Related]
3. Sodium molybdate increases the amount of progesterone and estrogen receptor detected in certain human breast cancer cytosols. Anderson KM; Phelan J; Marogil M; Hendrickson C; Economou S Steroids; 1980 Mar; 35(3):273-80. PubMed ID: 7189611 [TBL] [Abstract][Full Text] [Related]
4. Molybdate and the molecular properties of the vervet monkey estrogen receptor. Potgieter HC; Klein T; Magagane F; Savage N; Wittliff JL J Steroid Biochem; 1986 Dec; 25(6):951-6. PubMed ID: 3795954 [TBL] [Abstract][Full Text] [Related]
5. Comparison of an estrogen receptor related protein, the ERD5 antigen, with estrogen and progesterone receptors in breast cancer patients. Smyth CM; Benn DE; Reeve TS Pathology; 1987 Jul; 19(3):219-22. PubMed ID: 3324021 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies for progesterone receptor assays and polymorphism studies in breast cancer. Comparison with radioligand assays. Goussard J; Magdelenat H; Martin PM; Lechevrel C; Roussel G Bull Cancer; 1988; 75(8):771-82. PubMed ID: 3052654 [TBL] [Abstract][Full Text] [Related]
7. Partial characterization of protease(s) in human breast cancer cytosols that can degrade estrogen and progesterone receptors selectively. Maeda K; Tsuzimura T; Nomura Y; Sato B; Matsumoto K Cancer Res; 1984 Mar; 44(3):996-1001. PubMed ID: 6362861 [TBL] [Abstract][Full Text] [Related]
8. Progestin and estrogen receptors in human meningioma. Blankenstein MA; Blaauw G; Lamberts SW Clin Neuropharmacol; 1984; 7(4):363-7. PubMed ID: 6509448 [TBL] [Abstract][Full Text] [Related]
13. 4 S oestrogen receptor isoforms and their distribution in breast cancer samples. Marsigliante S; Baker VA; Puddefoot J; Barker S; Vinson GP J Mol Endocrinol; 1991 Dec; 7(3):205-11. PubMed ID: 1777042 [TBL] [Abstract][Full Text] [Related]
14. Simultaneous identification of estrogen and progesterone receptors by HPLC using a double isotope assay. Folk P; Dong J; Wittlife JL J Steroid Biochem Mol Biol; 1992 Apr; 42(2):141-50. PubMed ID: 1567780 [TBL] [Abstract][Full Text] [Related]
15. Isoelectric focusing of oestradiol receptor protein from human mammary carcinoma--a comparison with dextran coated charcoal assay. Lloyd EJ; Barnes DM; Skinner LG J Steroid Biochem; 1982 Feb; 16(2):239-44. PubMed ID: 6176783 [TBL] [Abstract][Full Text] [Related]
16. Effects of temperature, storage and sodium molybdate on the analysis of estrogen and progesterone receptors in rabbit uterine tissue and gynecologic tumor. Leung BS Horm Res; 1984; 19(4):243-52. PubMed ID: 6745845 [TBL] [Abstract][Full Text] [Related]
17. Hypermethylation pattern of ESR and PgR genes and lacking estrogen and progesterone receptors in human breast cancer tumors: ER/PR subtypes. Pirouzpanah S; Taleban FA; Mehdipour P; Sabour S; Atri M Cancer Biomark; 2018 Feb; 21(3):621-638. PubMed ID: 29278880 [TBL] [Abstract][Full Text] [Related]
18. Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors. Wiebe JP; Zhang G; Welch I; Cadieux-Pitre HA Breast Cancer Res; 2013 May; 15(3):R38. PubMed ID: 25927181 [TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor cleavage and plasminogen activation by enzymes in human breast tumor cytosol. Sherman MR; Tuazon FB; Miller LK Endocrinology; 1980 Jun; 106(6):1715-27. PubMed ID: 6989588 [TBL] [Abstract][Full Text] [Related]
20. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization. Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]